• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Genworth Financial Inc

    5/22/26 12:29:04 PM ET
    $GNW
    Life Insurance
    Finance
    Get the next $GNW alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001227758
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    GENWORTH FINANCIAL INC
    SEC File Number
    001-32195
    Address of Issuer
    11011 WEST BROAD STREET
    GLEN ALLEN
    VIRGINIA
    23060
    Phone
    804-281-6000
    Name of Person for Whose Account the Securities are To Be Sold
    RESTREPO ROBERT P JR
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Director

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common
    Fidelity Brokerage Services LLC
    900 Salem Street
    Smithfield � RI � 02917
    50000456053.3738300925605/22/2026
    NYSE


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common05/18/2024Restricted Stock VestingIssuerCheckbox not checked2741305/18/2024Compensation
    Common05/23/2025Restricted Stock VestingIssuerCheckbox not checked2258705/23/2025Compensation

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Nothing to ReportCheckbox checked

    144: Remarks and Signature

    Remarks
    Date of Notice
    05/22/2026

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Robert Restrepo

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $GNW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GNW

    DatePrice TargetRatingAnalyst
    6/18/2025$9.00Mkt Perform → Outperform
    Keefe Bruyette
    More analyst ratings

    $GNW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Genworth Financial Announces Results of Annual Meeting

    Genworth Financial, Inc. (NYSE:GNW) announced the election of all ten director nominees at its 2026 annual meeting of stockholders today. The board members re-elected were G. Kent Conrad, Karen E. Dyson, Jill R. Goodman, Melina E. Higgins, Thomas J. McInerney, Howard D. Mills, III, Robert P. Restrepo Jr., Elaine A. Sarsynski, Ramsey D. Smith, and Steven C. Van Wyk. At the annual meeting, stockholders also approved the advisory vote on named executive officer compensation and the 2026 Associate Stock Purchase Plan. In addition, stockholders ratified the selection of KPMG LLP as Genworth's independent registered public accounting firm for 2026. About Genworth Financial Genworth Financial,

    5/20/26 4:30:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    Genworth Financial Announces First Quarter 2026 Results

    Strategic Highlights Strong capital returns from Enact, with $99M received in the quarter Repurchased $66M of shares in the quarter; $856M since program inception as of March 31, 2026 CareScout delivered 1,486 matches1 in the quarter with 97% home care coverage of the aged 65-plus census population in the United States Continued progress on the LTC2 MYRAP3 with approximately $34.5B estimated net present value achieved since 2012 from IFAs4 Financial Highlights Net income5 of $47M, or $0.12 per diluted share, and adjusted operating income, excluding Closed Block5,6 of $109M, or $0.28 per diluted share Enact reported adjusted operating income of $140M5 in the quarter; PMI

    5/5/26 4:15:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    Climbing Into His 90s: Dr. Art Ulene and CareScout Challenge Assumptions About Aging

    Former TODAY Show medical correspondent to climb Mt. Kilimanjaro in July CareScout today announced an initiative with Dr. Art Ulene, the nationally recognized physician and former TODAY Show medical correspondent, tied to his planned July ascent of Mount Kilimanjaro at age 89 – a climb that will culminate as he turns 90. The partnership centers on a simple but expansive idea: showing what's possible at any age. The engagement will use Ulene's Kilimanjaro climb as a national storytelling moment aimed at reframing how Americans think about aging – moving the conversation away from limitation and toward preparation, agency, and continued purpose. The effort aligns with CareScout's mission

    4/29/26 10:00:00 AM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    SEC Filings

    View All

    SEC Form 144 filed by Genworth Financial Inc

    144 - GENWORTH FINANCIAL INC (0001276520) (Subject)

    5/22/26 12:29:04 PM ET
    $GNW
    Life Insurance
    Finance

    Genworth Financial Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - GENWORTH FINANCIAL INC (0001276520) (Filer)

    5/21/26 4:15:23 PM ET
    $GNW
    Life Insurance
    Finance

    SEC Form SCHEDULE 13G filed by Genworth Financial Inc

    SCHEDULE 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

    5/13/26 3:56:09 PM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO; Director Mcinerney Thomas J gifted 200,000 shares, decreasing direct ownership by 4% to 5,168,883 units (SEC Form 4)

    4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

    5/28/26 4:15:28 PM ET
    $GNW
    Life Insurance
    Finance

    President and CEO; Director Mcinerney Thomas J sold $927,000 worth of shares (100,000 units at $9.27), decreasing direct ownership by 2% to 5,368,883 units (SEC Form 4)

    4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

    5/27/26 4:15:35 PM ET
    $GNW
    Life Insurance
    Finance

    Director Restrepo Robert P Jr sold $456,055 worth of shares (50,000 units at $9.12), decreasing direct ownership by 35% to 92,655 units (SEC Form 4)

    4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

    5/26/26 4:16:46 PM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Genworth Financial upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Genworth Financial from Mkt Perform to Outperform and set a new price target of $9.00

    6/18/25 7:44:47 AM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    Leadership Updates

    Live Leadership Updates

    View All

    CareScout, a Genworth Company, Aims to Redefine Quality and Build Trust in Long-Term Care

    CareScout Quality Network brings together providers committed to person-centered care. CareScout today introduced the CareScout Quality Network, a first-of-its-kind group of long-term care providers who meet high standards for quality, person-centered care. "The long-term care industry is ripe for innovation because health and social systems aren't built to support the demand of our rapidly aging population. Older adults and their families are left to navigate a fragmented and confusing experience to find care," said Samir Shah, CEO of CareScout Services. "Quality measures today only meet the lowest common denominator of patient safety, which is important, but provides zero insight into

    2/13/24 8:30:00 AM ET
    $GNW
    Life Insurance
    Finance

    Genworth And Oceanwide Provide Transaction Update; Genworth To Focus on Contingency Plan

    RICHMOND, Va., Jan. 4, 2021 /PRNewswire/ -- Genworth Financial, Inc. (NYSE: GNW) (Genworth, the Company) and China Oceanwide Holdings Group Co., Ltd. (Oceanwide) today provided an update on their pending transaction. Given uncertainty around the completion and timing of the remaining steps required to close the transaction, Genworth and Oceanwide have not extended the current December 31, 2020 "end date" under the merger agreement. Oceanwide has indicated that the factors contributing to the delay since the parties agreed to their most recent extension of the merger agreement on November 30, 2020 were: (a) the finalization of the Hony Capital financing terms; and (b) the COVID-19 pandemi

    1/4/21 7:00:00 AM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Genworth Financial Inc

    SC 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

    10/25/24 3:16:06 PM ET
    $GNW
    Life Insurance
    Finance

    SEC Form SC 13G/A filed by Genworth Financial Inc (Amendment)

    SC 13G/A - GENWORTH FINANCIAL INC (0001276520) (Subject)

    2/13/24 5:06:12 PM ET
    $GNW
    Life Insurance
    Finance

    SEC Form SC 13G filed by Genworth Financial Inc

    SC 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

    2/9/24 9:59:00 AM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    Financials

    Live finance-specific insights

    View All

    Genworth Financial Announces First Quarter 2026 Results

    Strategic Highlights Strong capital returns from Enact, with $99M received in the quarter Repurchased $66M of shares in the quarter; $856M since program inception as of March 31, 2026 CareScout delivered 1,486 matches1 in the quarter with 97% home care coverage of the aged 65-plus census population in the United States Continued progress on the LTC2 MYRAP3 with approximately $34.5B estimated net present value achieved since 2012 from IFAs4 Financial Highlights Net income5 of $47M, or $0.12 per diluted share, and adjusted operating income, excluding Closed Block5,6 of $109M, or $0.28 per diluted share Enact reported adjusted operating income of $140M5 in the quarter; PMI

    5/5/26 4:15:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    Genworth Financial Schedules Earnings Conference Call for May 6

    Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing first quarter results after the market closes on May 5, 2026. A conference call will be held on May 6, 2026, at 9:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's May 6 conference call is 800-330-6710 or 213-279-1505 (outside the U.S.); conference ID #5100219. To participate in the call by we

    4/9/26 4:10:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    Genworth Financial Announces Fourth Quarter 2025 Results

    Strategic Highlights Executed $94M in share repurchases in the quarter; $245M in 2025 and $790M since program inception as of December 31, 2025 Delivered 925 matches with home care providers1 in the CareScout Quality Network in the quarter with over 95% home care coverage of the aged 65-plus census population in the United States Closed acquisition of Seniorly, Inc. for total cash consideration of $15M Care Assurance launched in October and was live in 39 states as of December 31, 2025 Continued progress on the LTC2 MYRAP3 with $100M of gross incremental premium approvals in the quarter; approximately $34.5B estimated net present value achieved since 2012 from IFAs4 Financ

    2/23/26 4:10:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance